Posted by Two Blokes
Buying stocks on a technical breakout isn't always the formula for a swift gain.
Source: Two Blokes Trading
Posted by Two Blokes
The GBP/USD surged during the North American session, rising back above the 1.36 figure as hostilities within
Source: Two Blokes Trading
Posted by Two Blokes
Strategist Tom Essaye explains why investors don't seem to care about the recent barrage of unfavorable develo
Source: Two Blokes Trading
Posted by Two Blokes
The internet is buzzing as the search for XRP, the fourth-largest cryptocurrency by market capitalization, hit
Source: Two Blokes Trading
Posted by Two Blokes
Consumers are making spending decisions in a haze of uncertainty about whether higher prices are the result of
Source: Two Blokes Trading
Posted by Two Blokes
INmune Bio offers a high-risk, high-reward opportunity ahead of its Phase 2 Alzheimer's readout. Lead asset XP
Source: Two Blokes Trading
Posted by Two Blokes
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHH
Source: Two Blokes Trading
Posted by Two Blokes
VANCOUVER, BC / ACCESS Newswire / June 16, 2025 / NexOptic Technology Corp. (TSXV:NXO) (the "Company") announc
Source: Two Blokes Trading
Posted by Two Blokes
To find the next 10-bagger, focus on small, profitable companies with 20%+ revenue growth, fair valuations, an
Source: Two Blokes Trading
Posted by Two Blokes
I'm initiating Tonix Pharmaceuticals Holding Corp. with a Buy rating, eyeing a rally on potential FDA approval
Source: Two Blokes Trading
Posted by Two Blokes
ORCL's Q4 AI growth is impressive but premium valuation suggests holding existing positions while new investor
Source: Two Blokes Trading
Posted by Two Blokes
With yet another war in the Middle East, defense stocks could rise significantly.
Source: Two Blokes Trading